The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...

Following in the footsteps of other pharmaceutical companies, Bristol Myers Squibb and Pfizer are offering Eliquis for cash-paying patients at a discount of 40% off the list price.

The companies’ new effort would bypass traditional middlemen to cut the drug’s monthly cost from a list price of around $606 ...

Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to ...

In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer ...

Pfizer's and Bristol-Myers Squibb's Eliquis will lead the market for stroke-preventing blood thinners after "best-in-class" clinical trial results that marry safety with effectiveness, analysts said.

Bleeding Risk: ELIQUIS increases the risk of bleeding and can cause serious, potentially fatal bleeding. Concomitant use of drugs affecting hemostasis increases the risk of bleeding including ...

Eliquis brought in roughly 240,000 prescriptions in January of last year, while Xarelto saw over 600,00 in the same month. In September of this year, Eliquis brought in 667,000, compared with ...

Eliquis’ efficacy in preventing strokes proved about as good as Pradaxa’s and slightly better than Xarelto’s. Pradaxa, which like Eliquis is dosed twice daily, demonstrated superior efficacy but not ...